RET and breast carcinoma: DOK4 is a positive regulator of the mitogen-activated protein kinase (MAPK) pathway [54], and it undergoes phosphorylation by the RET tyrosine kinase, whose over-expression is observed in estrogen receptor (ER)-positive breast cancer [55].